A Single-Dose, Open-Label, Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With IBS-C
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
A Single-Dose, Open-Label, Extension Study to Evaluate the Sustainability of the Effects of
SYN-010 in Patients with Irritable Bowel Syndrome with Constipation